Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

XPeng Q4 Adj EPADS $(0.28) Beats $(0.46) Estimate, Sales $1.84B Miss $1.86B Estimate

Author: Benzinga Newsdesk | March 19, 2024 06:02am
XPeng (NYSE:XPEV) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.46) by 39.13 percent. This is a 24.32 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $1.84 billion which missed the analyst consensus estimate of $1.86 billion by 1.18 percent. This is a 146.63 percent increase over sales of $745.28 million the same period last year.

Posted In: XPEV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist